By Evan Weinberger ( February 10, 2010, 3:07 PM EST) -- A New Jersey state judge has preliminarily approved a settlement of a Vioxx-related shareholder derivative action that will see Merck & Co. Inc. institute stronger drug-safety measures, appoint a chief medical officer and pay nearly $12.2 million in attorneys' fees....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.